Beta-blockers after acute myocardial infarction
36 results
1 - 36
Beta-blockers after acute myocardial infarction 
Continued beta-blocker use after acute myocardial infarction (AMI) reduces hospitalizations but not cardiovascular death, AMI, or stroke
Beta‐blockers in patients without heart failure after myocardial infarction- Beta-blockers in patients without heart failure after myocardial infarction
- Beta‐blockers for suspected or diagnosed acute myocardial infarction
- Acute coronary syndrome
- Chronic coronary syndrome (coronary heart disease)
- Sick sinus syndrome
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity
- Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an acute cardiovascular event
- Ventricular tachycardia
- In ACS, 5 yrs of invasive tx decreases MI but not all cause mortality (FRISC-II)
- Cerebral infarction (ischaemic stroke)
- The use of diltiazem, verapamil and short-acting nifedipine in heart failure
- Preoperative assessment
- Syncope: causes and investigations
- Interpretation of adult ECG
- Management of acute atrial fibrillation
- Prehospital emergency care
- Niacin not effective in CAD with low HDL cholesterol (AIM-HIGH)
- Chronic heart failure
- Aldosterone receptor antagonists spironolactone and eplerenone for congestive heart failure